Concord Wealth Partners’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Concord Wealth Partners's OGN Position: Q2 2026 in Review
Concord Wealth Partners opened a new position in Organon & Co (OGN) in Q2 2026: 10 shares worth $135. The stake represents ﹤0.01% of the portfolio and ranks #858 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in OGN as recently as Q4 2025.
Concord Wealth Partners first reported a position in OGN in Q2 2021 and has held it in 18 quarters since. The position peaked at $49K in Q2 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Concord Wealth Partners held 10 shares of Organon & Co worth $135 as of Q2 2026.
- Organon & Co was a new Concord Wealth Partners position in Q2 2026.
- Organon & Co made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #858 holding.
- Concord Wealth Partners first reported a position in Organon & Co in Q2 2021 and has held it in 18 quarters since.
- Concord Wealth Partners's Organon & Co position peaked at $49K in Q2 2022.
- 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.